Concepedia

Daniel Obando

DO

Statistics

Publications

8

Citations

359

H-Index

8

Active since

2005

Affiliations

The University of Sydney(Current)

Westmead Institute

Daniel Obando is an author at The University of Sydney specializing in antifungal agents, antifungal therapy, and new antifungal agents.

Publications per year

2005–2018

8

Publications

8

Hexadecylphosphocholine (Miltefosine) Has Broad-Spectrum Fungicidal Activity and Is Efficacious in a Mouse Model of Cryptococcosis

Fred Widmer, Lesley C. Wright, Daniel Obando et al. · Antimicrobial Agents and Chemotherapy · 2006 · 148 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Conjugates of Desferrioxamine B (DFOB) with Derivatives of Adamantane or with Orally Available Chelators as Potential Agents for Treating Iron Overload

Joe Liu, Daniel Obando, Liam G. Schipanski et al. · Journal of Medicinal Chemistry · 2009 · 50 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis, antifungal and antimicrobial activity of alkylphospholipids

Daniel Obando, Fred Widmer, Lesley C. Wright et al. · Bioorganic & Medicinal Chemistry · 2007 · 39 citations

Life Sciences, Biochemistry, Microbiology +12

Correlation of Antifungal Activity with Fungal Phospholipase Inhibition Using a Series of Bisquaternary Ammonium Salts

Clarissa K. L. Ng, Daniel Obando, Fred Widmer et al. · Journal of Medicinal Chemistry · 2005 · 39 citations · Full text

Life Sciences, Medicinal Chemistry, Microbiology +17

Lipophilic adamantyl- or deferasirox-based conjugates of desferrioxamine B have enhanced neuroprotective capacity: implications for Parkinson disease

Jeffrey R. Liddell, Daniel Obando, Joe Liu et al. · Free Radical Biology and Medicine · 2013 · 30 citations · Full text

Medicine, Neuroscience, Pharmacology +17

1–5 of 8